Article info

Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective

Authors

  1. Correspondence to Dr Li Yang; lyang{at}bjmu.edu.cn
View Full Text

Citation

Wei X, Zhao J, Yang L
Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective

Publication history

  • Received June 29, 2020
  • Revised October 29, 2020
  • Accepted November 4, 2020
  • First published November 27, 2020.
Online issue publication 
November 27, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.